3WHO THELEP. Persisting Mycobacterium Leprae Among THELEP Trial Patients in Bamako and Chingleput. Lep Rev 1987,58:325-337.
4Pierre J, Ji BH. The marchoux chemotherapy study group. Relapse after Long - Term follow up of multibacillary patients treated by WHO multidrug regimen. Int J Lepr 1995,63:195 -201.
5Girdhar BK, Girdhar A, Kumar A. Relapses in multibacillary leprosy patients: Effect of length of therapy. Lepr Rev 2000, 71 : 144 -153.
6WHO TDR. Elimination of Leprosy as a Public Health Problem-Current Status and Challenges Ahead. WHO TDR/SWG/2002, 57- 71.
7Meima A. The Future in Incidence of leprosy: A Scenario Analysis. Bull WHO 2004, 82:373 - 380.
9WHO. Enhanced global strategy for further reducing the disease burden due to leprosy ( Plan period: 2011 - 2015 ) [K]. New Delhi:WHO Regional Office for South-East Asia, 2009.
10WHO. Informal consultation on innovative approaches to further reduce leprosy burden in counties [ K ]. New Delhi : WHO Regional Office for South - East Asia, 2008.
